Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutual stimulatory signaling between human myogenic cells and rat cerebellar neurons. | Physiol Rep | 2021 | 34713978 | PubTator, text mining | PubMed |
| COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series. | Vaccines (Basel) | 2021 | 34696220 | PubTator, text mining | PubMed |
| Nivolumab, a Double-Edged Sword: A Case Report of Nivolumab-Induced Myasthenia Gravis. | J Med Cases | 2021 | 34691341 | PubTator, text mining | PubMed |
| MuSK not MNGIE: Atypical MuSK-antibody myasthenia presenting as a genetic disorder. | Neuromuscul Disord | 2021 | 34690051 | PubTator, text mining | PubMed |
| Prolonged sub-lethal exposure to galaxolide (HHCB) and tonalide (AHTN) promotes the metastatic potential of glioblastoma tumor spheroids. | Neurotoxicology | 2021 | 34687775 | PubTator, text mining | PubMed |
| The Lived Experience of Myasthenia Gravis: A Patient-Led Analysis. | Neurol Ther | 2021 | 34687427 | PubTator, text mining | PubMed |
| ROR and RYK extracellular region structures suggest that receptor tyrosine kinases have distinct WNT-recognition modes. | Cell Rep | 2021 | 34686333 | PubTator, text mining | PubMed |
| Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity? | Medicina (Kaunas) | 2021 | 34684066 | PubTator, text mining | PubMed |
| Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape. | Cancers (Basel) | 2021 | 34680351 | PubTator, text mining | PubMed |
| New Challenges Resulting From the Loss of Function of Nav1.4 in Neuromuscular Diseases. | Front Pharmacol | 2021 | 34671263 | PubTator, text mining | PubMed |
| Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges. | Cureus | 2021 | 34667659 | PubTator, text mining | PubMed |
| Idiopathic Bilateral Extraocular Myositis in a Subject With Poorly Controlled Type 2 Diabetes Mellitus: Case Report. | Front Med (Lausanne) | 2021 | 34660622 | PubTator, text mining | PubMed |
| Mechano-Signaling Aspects of Hepatocellular Carcinoma. | J Cancer | 2021 | 34659531 | PubTator, text mining | PubMed |
| Genome-Wide Association of Proprotein Convertase Subtilisin/Kexin Type 9 Plasma Levels in the ELSA-Brasil Study. | Front Genet | 2021 | 34659352 | PubTator, text mining | PubMed |
| Clinical Predictors of Prolonged Hospital Stay in Patients with Myasthenia Gravis: A Study Using Machine Learning Algorithms. | J Clin Med | 2021 | 34640412 | PubTator, text mining | PubMed |
| Fetal akinesia deformation sequence and massive perivillous fibrin deposition resulting in fetal death in six fetuses from one consanguineous couple, including literature review. | Mol Genet Genomic Med | 2021 | 34636181 | PubTator, text mining | PubMed |
| Molecular insight into the affinity, specificity and cross-reactivity of systematic hepatocellular carcinoma RALT interaction profile with human receptor tyrosine kinases. | Amino Acids | 2021 | 34618235 | PubTator, text mining | PubMed |
| Thymus pathology in myasthenia gravis with anti-acetylcholine receptor antibodies and concomitant Hashimoto's thyroiditis. A four-case series and literature review. | Rom J Morphol Embryol | 2021 | 34609410 | PubTator, text mining | PubMed |
| To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis. | Front Immunol | 2021 | 34603311 | PubTator, text mining | PubMed |
| The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review. | J Neuroimmune Pharmacol | 2021 | 34599742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=55